The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...
What is the work you’re leading at KaliVir as CEO? Our goal is to develop viral treatments that can reach and eliminate cancer cells in the body, bringing us closer to a cure for all cancer patients.
Trials in Progress: The Power of Timely Cancer Clinical Trial Communication Gastric cancer (GC) and esophageal cancer (EC) are the fifth and seventh leading causes of cancer-related mortality globally ...
Morning Overview on MSN
New therapy approach raises hopes for long-lasting autoimmune remission
In 2021, a woman with severe lupus at University Hospital Erlangen in Germany became the first person to receive CAR-T cell ...
Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.
Gastroenteropancreatic neuroendocrine carcinoma (NEC) represents a challenging subset of extrapulmonary neuroendocrine tumors, predominantly originating in the gastrointestinal tract. These poorly ...
A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an often-overlooked aspect of water chemistry, may play a role in regulating genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results